General MedicationsORALGeneric
POTIGA
EZOGABINE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview POTIGA is listed in Drugs@FDA under application 022345 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EZOGABINE Form and strength TABLET;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2016-05-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview POTIGA is listed in Drugs@FDA under application 022345 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EZOGABINE Form and strength TABLET;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2016-05-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.